PHGDH and breast carcinoma: Genetic or pharmacological inhibition of PHGDH by NCT-503 preferentially impaired the growth of PHGDH-amplified breast cancer cells in bone marrow-mimicking conditions and in intra-tibial xenograft models by inducing oxidative stress and nucleotide depletion (Possemato et al., 2011).